These findings demonstrated the crucial role of S100A8/A9 in disrupting the pulmonary vascular barrier during sepsis (Fig. 2F-G), which, to the best of our knowledge, represents the first study of its kind. This evidence concerns the gene IGKV1D-22 and Sepsis.